Table 2.
List and frequency of grade ≥3 adverse events
| Adverse event | N (%) | Grade |
|---|---|---|
| Dyspnea | 1 (4.5) | 3 |
| Anemia | 1 (4.5) | 3 |
| Back pain | 1 (4.5) | 3 |
| Elevated creatinine | 1 (4.5) | 3 |
| Facial edema around eyes | 1 (4.5) | 3 |
| Generalized weakness | 1 (4.5) | 3 |
| Hyperbilirubinemia | 2 (9) | 3 |
| Hyperglycemia | 1 (4.5) | 3 |
| Hypoalbuminemia | 2 (9) | 3 |
| Hypocalcemia | 1 (4.5) | 3 |
| Hyponatremia | 1 (4.5) | 3 |
| Hypophosphatemia | 1 (4.5) | 3 |
| Increased alkaline phosphatase | 1 (4.5) | 3 |
| Increased lipase | 1 (4.5) | 3 |
| Leukopenia | 2 (9) | 3 |
| Neutrophil count decreased | 1 (4.5) | 3 |
| Pleural effusion | 1 (4.5) | 3 |
| Hyperbilirubinemia | 1 (4.5) | 4 |